An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.
Medical literature on Tysabri associated Progressive Multifocal Leukoencephalopathy risk: Key Facts & Context โ detailed background and analysis.
Reference: PubMed Central (PMC)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: MedlinePlus โ Trusted Health Information
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: European Medicines Agency (EMA)
Authoritative source for clinical, regulatory, and public-health background reading.